Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging (NCT06460077) | Clinical Trial Compass
By InvitationNot Applicable
Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging
Finland15 participantsStarted 2024-10-03
Plain-language summary
This is an open, follow-up study to compare the performance of three critical imaging methods to detect chronic active lesions in Multiple Sclerosis (MS) in vivo.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Signing the informed consent form
* MS diagnosis in accordance with McDonald 2017 criteria
* Available longitudinal brain MR images (minimum 1 year)
* Simultaneous QSM MRI sequence and TSPO-PET
* Lesions with iron rim/s
Exclusion Criteria:
* Patients with other neurodegenerative disease than MS
* Patients with other autoimmune disease than MS
* Patients with other significant or malignant underlying disease of any other organ system
* Patients that are pregnant or breast-feeding
* Corticosteroid treatment within 4 weeks of imaging
* Patients with significant abnormal findings other than MS in the screening MRI
* Patients with claustrophobia, or a history of moderate to severe anxiety disorder or panic attacks (which could potentially lead to preterm termination of the imaging)
* Contraindication to PET scan investigations
* Exposure to experimental radiation in the past 12 months such that radiodosimetry limits would be exceeded by participating in this study
* Intolerance to previous PET scans; i.e. previous hypersensitivity reactions to any PET ligand or imaging agent or failure to participate in and comply with previous PET scans